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Two cases of Plasmodium knowlesi infection were 
identiﬁ  ed in humans in Cambodia by 3 molecular detection 
assays and sequencing. This ﬁ  nding conﬁ  rms the widespread 
distribution of P. knowlesi malaria in humans in Southeast 
Asia. Further wide-scale studies are required to assess the 
public health relevance of this zoonotic malaria parasite.
I
n Cambodia, malaria ranks among the leading causes 
of illness and death. Mostly affecting the ≈3 million 
persons (23% of Cambodia’s population) who live near 
forested areas, malaria remains an occupational disease 
in speciﬁ  c high-risk groups, such as forestry workers and 
migrant populations who have come into forested areas. 
However, for the past decade, the number of reported 
malaria cases has generally decreased but in a sawtooth 
pattern of periodic increases (1).
Four of the 5 Plasmodium species known to cause 
malaria in humans have already been described in 
Cambodia (2,3). P. falciparum remains the most frequent 
cause of malaria (83,777 cases in 2009, prevalence of 
70%) (1). However, distributions of Plasmodium species 
are changing, with a particularly substantial increase of 
P. vivax malaria cases, from 4,105 (8%) cases in 2000 to 
6,250 (25%) in 2009. In several areas of low transmission, 
the proportion of P. vivax infections has increased up to 
50% (2). This trend is probably related to various effective 
control strategies implemented in Cambodia against P. 
falciparum malaria.
No studies in humans (3) and monkeys in Cambodia 
have identiﬁ  ed the simian malaria parasite, P. knowlesi, 
which is causing human disease in some other countries 
in Southeast Asia (4).  P. knowlesi parasites were not 
detected in blood samples collected during 2004–2007 
from 138 monkeys (102 Macaca fascicularis monkeys; 
13 M. leonina monkeys; 20 Hyobates pileatus monkeys; 
2  Presbytis cristata monkeys; and 1 Pongo pygmaeus 
monkey) by using PCR (cytb and cox1 genes) (L. Duval, 
unpub. data). Because these animals were conﬁ  scated 
by Wildlife Alliance rescue patrols from illegal traders, 
the locations where they were trapped in Cambodia are 
unknown.
We undertook a cross-sectional prospective study 
in 3 sites in Cambodia (Figure, panel A) (5). The main 
objective of this study was to develop evidence to guide 
the management of malaria parasite–negative persons with 
acute febrile illness and to determine whether such persons 
were infected with P. knowlesi.
The Study
We enrolled patients >7 years of age with acute (<8 
days) febrile illness in selected outpatient clinics, where they 
had been tested for malaria by using rapid diagnostic test 
(CareStart, Access Bio Inc, Somerset, NJ, USA). A subset 
of nonfebrile patients were used as controls; patients in a 
critical clinical condition were excluded. After we obtained 
informed consent, each patient’s history was taken, a 
physical examination was conducted, and blood and throat 
swab samples were collected. The deﬁ   ned test battery, 
including the following pathogens, was performed by using 
a PCR/sequencing approach: Plasmodium spp., Leptospira 
spp., Rickettsia spp. (including Orientia tsutsugamushi), 
dengue viruses, Japanese encephalitis virus, and inﬂ  uenza 
viruses. HIV infection and tuberculosis were not evaluated. 
DNA and RNA from the erythrocyte pellet or throat swab 
were extracted by using the QIAamp kit (QIAGEN, Hilden, 
Germany), according to the manufacturer’s instructions. 
Malaria parasites were detected by using a Plasmodium 
spp.–speciﬁ  c nested PCR based on the cytb gene followed 
by sequencing (6).
During December 2007–December 2010, a total of 
1,475 patients were enrolled (621 in Soun Kouma; 650 
in Ou Chra, Pailin Province; and 204 in Snoul, Kratié 
Province), comprising 1,193 febrile and 282 nonfebrile 
persons. For 564 (38.2%) patients, no pathogens were 
detected. A total of 754 patients (51.1%; 676 cases, 78 
controls) were infected with malaria parasites, and the 
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distribution of Plasmodium spp. was as follows: P. vivax, 
51.6%;  P. falciparum, 40.6%; P. vivax/P. falciparum, 
7.4%; P. knowlesi, 0.3%; and P. ovale, 0.1%.
We detected P. knowlesi infections in 2 patients from 
Ou Chra health center in Pailin Province (Figure, panel B). 
The ﬁ  rst patient was a 41-year-old man from Borhuytbong 
village. He came in April 2010 to the health center with 
fever (38.5°C), chills, and headache. Rapid diagnostic 
test and microscopy were negative for malaria; PCR/
sequencing was positive for P. knowlesi. No other pathogen 
was found. The patient was originally from Thailand and 
reported that he had not returned to Thailand since getting 
married in Cambodia in 1989. He reported self-treatment 
with meﬂ  oquine (Lariam [Roche, Basel, Switzerland]) and 
was cured in 3 days. He further added that he used to hunt 
and spent most of his time in forests around Pailin, where 
long-tailed macaques, the natural hosts of P. knowlesi (7), 
are usually found. 
The second patient was a 40-year-old Khmer man 
from Phnomdambang village. He came in September 
2010 to the health center because of chills and headache. 
No fever (36°C) was detected by the medical staff, 
but the patient reported a history of fever and had self-
treated with acetaminophen. Results of rapid diagnostic 
test were negative, but microscopy results were positive 
(33 parasites/μL) (Figure, panel C). PCR ampliﬁ  cation 
followed by sequencing conﬁ  rmed P. knowlesi infection. 
No other pathogen was found. The patient reported having 
lived in this same village since 1995, and he frequently 
went to the forests around Pailin for hunting and collecting 
valued wood. 
Both patients’ P. knowlesi infections were conﬁ  rmed 
by additional PCR ampliﬁ  cation and sequencing of the ldh, 
tufA, and cox genes (8) at the Genomic Platform, Institut 
Pasteur, Paris, France. Blood spots on ﬁ  lter paper were 
also sent blinded to the Malaria Research Centre, Faculty 
of Medicine and Health Sciences, University Malaysia, 
Sarawak, Malaysia, where they were identiﬁ  ed  as  P. 
knowlesi single infections by real-time PCR (9) and by 
nested PCR with the primers Pmk8 and Pmkr9 (10) and 
PkF1140 and PkR1550 (11). The nucleotide sequence 
determined in this study has been deposited in the GenBank 
database and assigned accession nos. JF419317–JF419323.
Conclusions
Our ﬁ  ndings conﬁ  rm that P. knowlesi infections occur 
in humans in Cambodia, thereby increasing the number 
of countries in Southeast Asia with cases in humans (10). 
However, further wide-scale studies are required to assess 
the prevalence and distribution of P. knowlesi malaria cases 
in humans and monkeys. Such studies would enable an 
assessment of the public health relevance of this zoonotic 
malaria parasite and characterization of P. knowlesi malaria 
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Figure. A) The 3 sites involved in the epidemiologic study of 
Plasmodium knowlesi malaria, Cambodia, 2007–2010. B) Villages 
in Pailin Province in which the 2 P. knowlesi malaria case-patients 
lived. C) Thin blood ﬁ  lm slide of 1 PCR-conﬁ  rmed P. knowlesi single 
infection (case C2611). Original magniﬁ  cation ×1,000.epidemiology in this region. They would be particularly 
useful in determining whether this simian species has 
been imported from neighboring countries by humans or 
whether P. knowlesi parasites are already circulating and 
are transmitted from monkey reservoir hosts to humans. 
Moreover, to address this issue, development of new tools, 
such as speciﬁ  c serologic markers, is urgently needed, in 
addition to molecular biology methods.
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